Phase 2 BRAF V600E Mutation Positive Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer
Colorectal, CancerBRAF V600E Mutation Positive
Federation Francophone de Cancerologie Digestive30 enrolled1 locationNCT05706779
Recruiting
Phase 2
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
BRAF V600E Mutation PositiveAmeloblastoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University12 enrolled1 locationNCT06653517